"Enhancing Turmeric's Effectiveness for Gut Health and Inflammation Treatment"
Researchers explore the potential of nano-formulations to enhance the bioavailability and bioactivity of curcumin, a bioactive compound in turmeric, to amplify its antioxidant properties and disease-preventing effects. Various nano-formulations have been developed to address curcumin's bioavailability limitations, showing promising outcomes in preclinical studies across various diseases. Curcumin exhibits therapeutic potential in diseases such as cancer, inflammation, neurodegeneration, liver diseases, and Alzheimer's. Clinical trials suggest positive effects of curcumin on body weight, body fat, and metabolic markers in overweight/obese individuals, as well as in the prevention of cardiovascular diseases. Further research in clinical settings is warranted to optimize curcumin's anti-inflammatory effects in human chronic inflammation.